Back to search

Peptide record

TPDB06149

Antibacterial Antiviral Toxicity standard
10 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB06149
Antibacterial Antiviral Toxicity
Anti-infective peptides Toxicity and safety peptides
AntiBP3 Peptipedia AI4AVP DRAVP 2.0
standard
No
A 10-aa standard natural multi-activity (Antibacterial, Antiviral, and Toxicity) peptide sequence curated from AntiBP3, Peptipedia, AI4AVP, and other sources, with an available 3D structural model.
Sequence
QKKIRVRLSA
Physicochemical Analysis
C52H99N19O13
NDCEGHMFPTWY
RK
1198.48
12.42
4
0
4
+4
3.34
-0.680
117.00
Mammalian: 0.8 hour Yeast: 10 min E.coli: >10 hour
0
0.00
2
Residue Composition
number
1
A
2
R
0
N
0
D
0
C
0
E
1
Q
0
G
0
H
1
I
1
L
2
K
0
M
0
F
0
P
1
S
0
T
0
W
0
Y
1
V
Amino Acid Distribution
A: 1 R: 2 N: 0 D: 0 C: 0 E: 0 Q: 1 G: 0 H: 0 I: 1 L: 1 K: 2 M: 0 F: 0 P: 0 S: 1 T: 0 W: 0 Y: 0 V: 1
Chemical Descriptors
10
C52H99N19O13
1198.48
12.42
+4
3.34
-0.680
Evidence Records 18 records
Evidence 1 Activity

Activity

MIC
Antibacterial
8 µg/mL

Target

Escherichia coli

Source & Reference

NA

Other

active against E. coli (MIC 8 ug/ml), P. aeruginosa ATCC 27853 or 885149 or 891 (MIC4-8 ug/ml), K. pneumoniae W99FI0057 (MIC 4
Evidence 2 Activity

Activity

MIC
Antibacterial
4-8 µg/mL

Target

Pseudomonas aeruginosa ATCC 27853 or 885149 or 891

Source & Reference

NA

Other

active against E. coli (MIC 8 ug/ml), P. aeruginosa ATCC 27853 or 885149 or 891 (MIC4-8 ug/ml), K. pneumoniae W99FI0057 (MIC 4-16 ug/ml), P. mirabilis W99FI0089 or W03VA1144 (64->128 u
Evidence 3 Activity

Activity

MIC
Antibacterial
4-16 µg/mL

Target

Klebsiella pneumoniae W99FI0057

Source & Reference

NA

Other

against E. coli (MIC 8 ug/ml), P. aeruginosa ATCC 27853 or 885149 or 891 (MIC4-8 ug/ml), K. pneumoniae W99FI0057 (MIC 4-16 ug/ml), P. mirabilis W99FI0089 or W03VA1144 (64->128 ug/ml), E. aerogenes W03BG0067 (MIC 4-8 ug/
Evidence 4 Activity

Activity

MIC
Antibacterial
4-8 µg/mL

Target

Enterobacter aerogenes W03BG0067

Source & Reference

NA

Other

eumoniae W99FI0057 (MIC 4-16 ug/ml), P. mirabilis W99FI0089 or W03VA1144 (64->128 ug/ml), E. aerogenes W03BG0067 (MIC 4-8 ug/ml), A. baumannii AB1MG (MIC 16-32 ug/ml), C. freundii W99FI00007 (MIC 16 ug/ml), B. epacia S
Evidence 5 Activity

Activity

MIC
Antibacterial
16-32 µg/mL

Target

A. baumannii AB1MG

Source & Reference

NA

Other

mirabilis W99FI0089 or W03VA1144 (64->128 ug/ml), E. aerogenes W03BG0067 (MIC 4-8 ug/ml), A. baumannii AB1MG (MIC 16-32 ug/ml), C. freundii W99FI00007 (MIC 16 ug/ml), B. epacia SMC71 (MIC 64 ug/ml), S.marcescens W99F
Evidence 6 Activity

Activity

MIC
Antibacterial
16 µg/mL

Target

Citrobacter freundii W99FI00007

Source & Reference

NA

Other

128 ug/ml), E. aerogenes W03BG0067 (MIC 4-8 ug/ml), A. baumannii AB1MG (MIC 16-32 ug/ml), C. freundii W99FI00007 (MIC 16 ug/ml), B. epacia SMC71 (MIC 64 ug/ml), S.marcescens W99FI0111 (MIC> 128 ug/ml), S.maltophilia P
Evidence 7 Activity

Activity

MIC
Antibacterial
64 µg/mL

Target

B. epacia SMC71

Source & Reference

NA

Other

4-8 ug/ml), A. baumannii AB1MG (MIC 16-32 ug/ml), C. freundii W99FI00007 (MIC 16 ug/ml), B. epacia SMC71 (MIC 64 ug/ml), S.marcescens W99FI0111 (MIC> 128 ug/ml), S.maltophilia PT4/99 (MIC >128 ug/ml), P.stuart
Evidence 8 Activity

Activity

MIC
Antibacterial
>128 µg/mL

Target

P.stuartii W03FI0001

Source & Reference

NA

Other

4 ug/ml), S.marcescens W99FI0111 (MIC> 128 ug/ml), S.maltophilia PT4/99 (MIC >128 ug/ml), P.stuartii W03FI0001 (MIC>128 ug/ml), S. aureus ATCC 25923 or MIU-68A (MIC 64->128 ug/ml). mainly acttive against Gram- bacter
Evidence 9 Activity

Activity

MIC
Antibacterial
64->128 µg/mL

Target

Staphylococcus aureus ATCC 25923 or MIU-68A

Source & Reference

NA

Other

128 ug/ml), S.maltophilia PT4/99 (MIC >128 ug/ml), P.stuartii W03FI0001 (MIC>128 ug/ml), S. aureus ATCC 25923 or MIU-68A (MIC 64->128 ug/ml). mainly acttive against Gram- bacteria.
Evidence 10 Activity

Activity

MIC
Antiviral
8 µg/mL

Target

Escherichia coli

Source & Reference

DRAVP 2.0

Other

active against E. coli (MIC 8 ug/ml), P. aeruginosa ATCC 27853 or 885149 or 891 (MIC4-8 ug/ml), K. pneumoniae W99FI0057 (MIC 4
Evidence 11 Activity

Activity

MIC
Antiviral
4-8 µg/mL

Target

Pseudomonas aeruginosa ATCC 27853 or 885149 or 891

Source & Reference

DRAVP 2.0

Other

active against E. coli (MIC 8 ug/ml), P. aeruginosa ATCC 27853 or 885149 or 891 (MIC4-8 ug/ml), K. pneumoniae W99FI0057 (MIC 4-16 ug/ml), P. mirabilis W99FI0089 or W03VA1144 (64->128 u
Evidence 12 Activity

Activity

MIC
Antiviral
4-16 µg/mL

Target

Klebsiella pneumoniae W99FI0057

Source & Reference

DRAVP 2.0

Other

against E. coli (MIC 8 ug/ml), P. aeruginosa ATCC 27853 or 885149 or 891 (MIC4-8 ug/ml), K. pneumoniae W99FI0057 (MIC 4-16 ug/ml), P. mirabilis W99FI0089 or W03VA1144 (64->128 ug/ml), E. aerogenes W03BG0067 (MIC 4-8 ug/
Evidence 13 Activity

Activity

MIC
Antiviral
4-8 µg/mL

Target

Enterobacter aerogenes W03BG0067

Source & Reference

DRAVP 2.0

Other

eumoniae W99FI0057 (MIC 4-16 ug/ml), P. mirabilis W99FI0089 or W03VA1144 (64->128 ug/ml), E. aerogenes W03BG0067 (MIC 4-8 ug/ml), A. baumannii AB1MG (MIC 16-32 ug/ml), C. freundii W99FI00007 (MIC 16 ug/ml), B. epacia S
Evidence 14 Activity

Activity

MIC
Antiviral
16-32 µg/mL

Target

A. baumannii AB1MG

Source & Reference

DRAVP 2.0

Other

mirabilis W99FI0089 or W03VA1144 (64->128 ug/ml), E. aerogenes W03BG0067 (MIC 4-8 ug/ml), A. baumannii AB1MG (MIC 16-32 ug/ml), C. freundii W99FI00007 (MIC 16 ug/ml), B. epacia SMC71 (MIC 64 ug/ml), S.marcescens W99F
Evidence 15 Activity

Activity

MIC
Antiviral
16 µg/mL

Target

Citrobacter freundii W99FI00007

Source & Reference

DRAVP 2.0

Other

128 ug/ml), E. aerogenes W03BG0067 (MIC 4-8 ug/ml), A. baumannii AB1MG (MIC 16-32 ug/ml), C. freundii W99FI00007 (MIC 16 ug/ml), B. epacia SMC71 (MIC 64 ug/ml), S.marcescens W99FI0111 (MIC> 128 ug/ml), S.maltophilia P
Evidence 16 Activity

Activity

MIC
Antiviral
64 µg/mL

Target

B. epacia SMC71

Source & Reference

DRAVP 2.0

Other

4-8 ug/ml), A. baumannii AB1MG (MIC 16-32 ug/ml), C. freundii W99FI00007 (MIC 16 ug/ml), B. epacia SMC71 (MIC 64 ug/ml), S.marcescens W99FI0111 (MIC> 128 ug/ml), S.maltophilia PT4/99 (MIC >128 ug/ml), P.stuart
Evidence 17 Activity

Activity

MIC
Antiviral
>128 µg/mL

Target

P.stuartii W03FI0001

Source & Reference

DRAVP 2.0

Other

4 ug/ml), S.marcescens W99FI0111 (MIC> 128 ug/ml), S.maltophilia PT4/99 (MIC >128 ug/ml), P.stuartii W03FI0001 (MIC>128 ug/ml), S. aureus ATCC 25923 or MIU-68A (MIC 64->128 ug/ml). mainly acttive against Gram- bacter
Evidence 18 Activity

Activity

MIC
Antiviral
64->128 µg/mL

Target

Staphylococcus aureus ATCC 25923 or MIU-68A

Source & Reference

DRAVP 2.0

Other

128 ug/ml), S.maltophilia PT4/99 (MIC >128 ug/ml), P.stuartii W03FI0001 (MIC>128 ug/ml), S. aureus ATCC 25923 or MIU-68A (MIC 64->128 ug/ml). mainly acttive against Gram- bacteria.